GlaxoSmithKline Biologicals withdraws its application for a scientific opinion for Globorix (PDF/33.57 KB)
First published: 16/10/2007
Last updated: 16/10/2007
Questions and answers on the withdrawal of the application for a scientific opinion for Globorix (PDF/37.9 KB)
First published: 24/10/2007
Last updated: 24/10/2007
Withdrawal assessment report for Globorix (PDF/1.08 MB)
First published: 18/12/2007
Last updated: 18/12/2007
The question-and-answer (Q&A) document provides a summary of the CHMP's evaluation of the medicine at the time of the withdrawal of the application, and includes a link to the company's formal withdrawal letter.
An assessment report is published when the application is withdrawn after the first stage of the CHMP's evaluation is completed ('day 120').